Sugiyama T - Search Results

1

A phase II clinical trial of topotecan in Japanese patients with relapsed ovarian carcinoma.

Aoki D, Katsumata N, Nakanishi T, Kigawa J, Fujiwara K, Takehara K, Kamiura S, Hiura M, Hatae M, Sugiyama T, Ochiai K, Noda K. Aoki D, et al. Among authors: sugiyama t. Jpn J Clin Oncol. 2011 Mar;41(3):320-7. doi: 10.1093/jjco/hyq192. Epub 2010 Oct 25. Jpn J Clin Oncol. 2011. PMID: 20974678 Clinical Trial.

2

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

Itamochi H, Kigawa J, Sugiyama T, Kikuchi Y, Suzuki M, Terakawa N. Itamochi H, et al. Among authors: sugiyama t. Obstet Gynecol. 2002 Aug;100(2):281-7. doi: 10.1016/s0029-7844(02)02040-9. Obstet Gynecol. 2002. PMID: 12151151

3

Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer.

Sugiyama T, Yakushiji M, Kamura T, Ikeda M, Umesaki N, Hasegawa K, Ishikawa M, Saji F, Hiura M, Takahashi T, Sato S, Ochiai K, Kikkawa F, Takeuchi S, Ohashi Y, Noda K; Japan CPT-11 Study Group. Sugiyama T, et al. Oncology. 2002;63(1):16-22. doi: 10.1159/000065715. Oncology. 2002. PMID: 12187066 Clinical Trial.

4

PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy.

Kanamori Y, Kigawa J, Itamochi H, Sultana H, Suzuki M, Ohwada M, Kamura T, Sugiyama T, Kikuchi Y, Kita T, Fujiwara K, Terakawa N. Kanamori Y, et al. Among authors: sugiyama t. Int J Cancer. 2002 Aug 20;100(6):686-9. doi: 10.1002/ijc.10542. Int J Cancer. 2002. PMID: 12209607

5

Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study.

Nishio S, Ota S, Sugiyama T, Matsuo G, Kawagoe H, Kumagai S, Ushijima K, Nishida T, Kamura T. Nishio S, et al. Among authors: sugiyama t. Int J Clin Oncol. 2003 Feb;8(1):45-8. doi: 10.1007/s101470300006. Int J Clin Oncol. 2003. PMID: 12601542

6

Japanese ovarian trials: focus on irinotecan.

Sugiyama T, Yakushiji M, Ochiai K, Noda K. Sugiyama T, et al. Oncology (Williston Park). 2003 May;17(5 Suppl 5):29-33. Oncology (Williston Park). 2003. PMID: 12800603 Review.

7

Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.

Hachisuga T, Saito T, Kigawa J, Ohwada M, Yamazawa K, Yasue A, Iwasaka T, Sugiyama T, Kita T, Nagai N. Hachisuga T, et al. Among authors: sugiyama t. Gynecol Oncol. 2004 Oct;95(1):139-44. doi: 10.1016/j.ygyno.2004.07.019. Gynecol Oncol. 2004. PMID: 15385123

8

[Ovarian cancer].

Sugiyama T. Sugiyama T. Gan To Kagaku Ryoho. 2005 Aug;32(8):1096-103. Gan To Kagaku Ryoho. 2005. PMID: 16121909 Review. Japanese.

9

Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.

Takano M, Kikuchi Y, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Sugiyama T. Takano M, et al. Among authors: sugiyama t. Oncol Rep. 2006 Dec;16(6):1301-6. Oncol Rep. 2006. PMID: 17089053

10

Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.

Takano M, Sugiyama T, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Kikuchi Y. Takano M, et al. Among authors: sugiyama t. Int J Clin Oncol. 2007 Aug;12(4):256-60. doi: 10.1007/s10147-007-0670-1. Epub 2007 Aug 20. Int J Clin Oncol. 2007. PMID: 17701003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,905 results

Search Page

Filters